treprostinil SC (Pending FDA Approval)

Brand and Other Names:Trevyent
Sections

Dosing & Uses

AdultPediatric

Pulmonary Arterial Hypertension

Patch/pump drug-device pending FDA approval that provides 2-day, disposable single-use, SC dose for pulmonary arterial hypertension (PAH)

Safety and efficacy not established

Next:

Pharmacology

Mechanism of Action

Peripheral prostacyclin vasodilator of both pulmonary and systemic arterial vascular bed; decreases ventricular afterload; also inhibits platelet aggregation

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.